Trials / Completed
CompletedNCT06990100
Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery : Post-market Clinical Follow-up Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- SACIMEX · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Anterior cruciate ligament (ACL) injuries are among the most common sports-related knee traumas. The DT4-EBMCA device, based on a quadrupled semitendinosus autograft technique, aims to provide effective and minimally invasive ligament reconstruction. This study evaluates its long-term performance and safety in routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ACL surgery | ligamentoplasty surgery - ACL reconstruction surgery |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-04-01
- Completion
- 2025-05-12
- First posted
- 2025-05-25
- Last updated
- 2025-05-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06990100. Inclusion in this directory is not an endorsement.